Save
Email
Print
Share
RSSBrowse News Stories
131 to 140 of 721 stories
view headlines only
-
Promising New Drug Could Help Patients Battling Deadly and Difficult to Treat Form of Melanoma
March 8, 2012 — Researchers say they may have discovered a new drug for the treatment of metastatic melanoma, one that uses the patient’s own tumor cells to customize the ... > full story -
Rare Medical Phenomenon of Systemic Tumor Disappearance Following Local Radiation Treatment Reported in a Patient With Metastatic Melanoma
March 7, 2012 — A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been ... > full storyMore: -
Potential Solution to Melanoma's Resistance to Vemurafenib
February 28, 2012 — Researchers have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with ... > full story -
Newly Approved Drug for Metastatic Melanoma Nearly Doubles Median Survival
February 22, 2012 — A newly approved drug for patients with metastatic melanoma nearly doubles median survival times, a finding that will change the way this deadly form of skin cancer is ... > full story -
Radiation Treatment Generates Cancer Stem Cells from Less Aggressive Breast Cancer Cells, Study Suggests
February 13, 2012 — Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don’t respond well to chemotherapy. Researchers report for ... > full story -
Nanotube Therapy Takes Aim at Breast Cancer Stem Cells
February 9, 2012 — Researchers have again shown that injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second laser treatment can kill ... > full story -
Collaborative Research Sheds Light on New Cancer Stem Cell Therapies
January 27, 2012 — New anti-cancer research has led to the development of a novel class of chemical inhibitors that specifically target cancer cells with ... > full story -
Mechanism by Which Newly Approved Melanoma Drug Accelerates Secondary Skin Cancers Uncovered
January 17, 2012 — Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf®) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. ... > full story -
Novel Brain Tumor Vaccine Acts Like Bloodhound to Locate Cancer Cells
January 5, 2012 — A national U.S. clinical trial testing the efficacy of a novel brain tumor vaccine has begun. The vaccine will be tested in patients with newly diagnosed glioblastoma multiforme (GBM), the most ... > full story -
Fibroblasts Contribute to Melanoma Tumor Growth
January 5, 2012 — Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also ... > full story
Search ScienceDaily
Number of stories in archives: 137,376
more 
